Theranexus Société Anonyme 3VG

Theranexus Société Anonyme, a biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders. It is involved in the development of Batten-1, an initial drug candidate currently under Phase ½ clinical study for Batten disease. The company was founded in 2013 and is headquartered in Lyon, France.

CEO

Mr. Mathieu Charvériat

Founded

2013

Employees

12

Sector

Healthcare

Industry

Biotechnology

Headquarters

LyonFrance

High Today

$0.37

Low Today

$0.37

Open Today

$0.37

Volume Today

2,569.0

52 Week High

$1.09

52 Week Low

$0.37

Average Volume

1,323